Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines
Completed
GlaxoSmithKline
Phase 3
2006-09-01
The purpose of this trial is to assess if the rate of febrile reactions following the
co-administration of pneumococcal conjugate vaccines with standard infant vaccines is lowered
when paracetamol is given prophylactically.
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
Completed
GlaxoSmithKline
Phase 3
2007-07-02
The purpose of this trial is to assess if the rate of febrile reactions following the
co-administration of a booster dose of pneumococcal conjugate vaccines with standard infant
vaccines is lowered when paracetamol is given prophylactically and to assess the impact of
pneumococcal conjugate vaccine on pneumococcal and H. influenzae nasopharyngeal carriage
compared to control group receiving meningococcal conjugate vaccine (GSK134612).
This protocol posting deals with objectives & outcome measures of the booster phase. The
objectives & outcome measures of the primary phase are presented in a separate protocol
posting (NCT number = NCT00370318).
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®
Completed
Pfizer
Phase 4
2011-08-01
The purposes of this study are assess the immunological response (measure the amount of
antibodies, i.e. proteins that fight off germs) produced by children after they have been
given the 13-valent pneumococcal vaccine (13vPnC) and INFANRIX hexa at 2, 3, 4 and 12 months
of age when medications to prevent fever are given on the same day as the vaccination. Also
to evaluate the safety of 13-valent pneumococcal conjugate vaccine (13vPnC) in children who
receive medications to prevent fever on the day of vaccination.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
